MED1-STARD3 Fusion FISH Probe
The MED1-STARD3 Fusion FISH Probe is used to confirm a fusion of the MED1 and STARD3 genes. The fusion of the MED1 and STARD3 genes has been associated with Esophageal Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| MED1-STARD3-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-RERE | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-REOR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-REGO | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-REGR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-OROR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GORE | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GROR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| MED1-STARD3-20-AQAQ | 20 (40 μL) | 200 μL |
|
MED1 Gene Summary
The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. It also regulates p53-dependent apoptosis and it is essential for adipogenesis. This protein is known to have the ability to self-oligomerize. [provided by RefSeq, Jul 2008]
Gene Name: Mediator Complex Subunit 1
Chromosome: CHR17: 37560537 -37607527
Locus: 17q12
STARD3 Gene Summary
This gene encodes a member of a subfamily of lipid trafficking proteins that are characterized by a C-terminal steroidogenic acute regulatory domain and an N-terminal metastatic lymph node 64 domain. The encoded protein localizes to the membranes of late endosomes and may be involved in exporting cholesterol. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Oct 2009]
Gene Name: StAR Related Lipid Transfer Domain Containing 3
Chromosome: CHR17: 37793332 -37820454
Locus: 17q12
Gene Diseases
The MED1 STARD3 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Esophageal Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|